Trial of a Harm Reduction Strategy for People With HIV Who Smoke Cigarettes
400
about 3 years
40–79
1 site in NY
About this study
This trial is testing whether a harm reduction strategy can help people with HIV who smoke cigarettes. The goal is to reduce the negative health effects associated with smoking in this population.
Based on ClinicalTrials.gov records.
What participants do
- 1.Participate in EX+
- 2.Participate in HR
- 3.Participate in TAU
- +1 more
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
varenicline
oral (Oral Tablet)
Primary: Change in systolic blood pressure (SBP)
Secondary: Proportion of participants at target low dose low-density lipoprotein (LDL) cholesterol, Proportion of participants at target systolic blood pressure, Proportion with undetectable HIV-1 viral load
Immune, Infectious